Acute Asthma or COPD with Wheezing - Revision history

Mfrdmanager at 13:24, 13 November 2020

2020-11-13T13:24:17Z

Mfrdmanager at 14:05, 13 February 2019

2019-02-13T14:05:43Z

Mfrdmanager: Protected "Acute Asthma or COPD with Wheezing" ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))

2018-02-10T13:49:05Z

Protected "Acute Asthma or COPD with Wheezing" ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))

Mfrdmanager: Created page with "==Section 3 - RESPIRATORY== === 3.01 ACUTE ASTHMA / COPD WITH WHEEZING=== INITIAL MEDICAL CARE (2.01) Obtain history of patient's curr..."

2018-02-01T19:24:57Z

Created page with "==Section 3 - RESPIRATORY== === 3.01 ACUTE ASTHMA / COPD WITH WHEEZING=== INITIAL MEDICAL CARE (2.01) Obtain history of patient's curr..."

New page

==Section 3 - RESPIRATORY==
=== 3.01 ACUTE ASTHMA / COPD WITH WHEEZING===

[[Initial Medical Assessment and Care|INITIAL MEDICAL CARE]] (2.01) Obtain history of patient's current respiratory medications and time of last dosage.

'''DO NOT DELAY TRANSPORT WAITING FOR RESPONSE OF TREATMENT.'''

:If bronchospasm worsens despite treatment, respiratory failure is imminent, or patient exhibits with an altered mental status, perform endotracheal intubation and ventilate with [[Medical Gases|OXYGEN]] @ 100% via BVM.
:

====Age GREATER than 13 years:====
* Assist ventilations with BVM, 100% [[Medical Gases|OXYGEN]] or Apply CPAP device as indicated.
* [[Bronchodilators|ALBUTEROL (PROVENTIL)]] 2.5 mg via updraft or CPAP device. After second updraft of [[Bronchodilators|ALBUTEROL]], consider [[Bronchodilators|IPRATROPIUM BROMIDE (ATROVENT)]] .5 mg via updraft. [[Bronchodilators|ATROVENT]] is not for use in CHF or Cardiac Asthma. Repeat as necessary while monitoring heart rate.
* If the Pt has had multiple updrafts or had previously used their own Albuterol inhaler or nebulized treatment and have not had relief. Consider [[Bronchodilators|XOPENEX (LEVALBUTEROL)]] 1.25mg nebulized via updraft.
* Administer [[Corticosteroids|METHYLPREDNISOLONE (SOLU-MEDROL)]] 125 mg IVP once the breathing treatment has been initiated.
* If no response to the above, consider [[Anesthetics|KETAMINE (KETALAR)]] 1 mg/kg IVP OR 2 mg/kg IM x 1 dose
* For deteriorating patients (if no renal disease or CHF is not suspected)
** Administer [[Electrolytes|MAGNESIUM SULFATE]] 2 gm IV in 100 ml NaCl via buretrol or secondary IV solution (piggyback), over 10-15 minutes.

:'''If condition unimproved or patient exhibits acute hypoxia EPINEPHRINE may be administered: 1:1000 1mg/ml 0.3 - 0.5 mg IM.'''

====Age LESS than 13 years: SLOW ONSET====
* [[Bronchodilators|ALBUTEROL (PROVENTIL)]] refer to Handtevy System.
** May administer second dosage if dyspnea unimproved.
* If patient exhibits acute dyspnea, as evidenced by AMS, administer [[Adrenergics|EPINEPHRINE 1:1000]] 1mg/ml refer to Handtevy System
* If the patient is not responding to the above interventions, administer [[Corticosteroids|METHYLPREDNISOLONE (SOLU-MEDROL)]], refer to Handtevy System.
* If no response to the above, consider [[Anesthetics|KETAMINE (KETALAR)]] 1 mg/kg IVP OR 2 mg/kg IM x 1 dose

====Age LESS than 13 years: RAPID ONSET====
* In patients with rapid onset respiratory compromise due to asthma or bronchospasm, [[Bronchodilators|ALBUTEROL (PROVENTIL)]] refer to Handtevy System simultaneous with IM [[Adrenergics|EPINEPHRINE]] 1:1000 (1mg/ml) every 10-15 minutes, refer to Handtevy System.
*If the Pt has had multiple updrafts or had previously used their own Albuterol inhaler or nebulized treatment and have not had relief. Consider [[Bronchodilators|XOPENEX (LEVALBUTEROL)]] nebulized via updraft refer to Handtevy System.
*Monitor heart rate. Continue therapy with heart rates <180-200 ages up to 6 years, <150-180 ages 6-18 years. Updrafts may need to be continuous.
*If the patient is not responding to the above interventions, administer [[Corticosteroids|METHYLPREDNISOLONE (SOLU-MEDROL)]], refer to Handtevy System.
*'''In the event of impending respiratory arrest and imminent death, [[Adrenergics|EPINEPHRINE]] may be administered IV or IM. (Dose for IV same as in cardiac arrest patient)'''

[[Category:Respiratory|0301]]

@@ Line 7: / Line 7: @@
 '''DO NOT DELAY TRANSPORT WAITING FOR RESPONSE OF TREATMENT.'''
-:If bronchospasm worsens despite treatment, respiratory failure is imminent, or patient exhibits with an altered mental status, perform endotracheal intubation and ventilate with [[Medical Gases|OXYGEN]] @ 100% via BVM.
+:If bronchospasm worsens despite treatment, respiratory failure is imminent, or patient exhibits with an altered mental status, perform endotracheal intubation and ventilate with [[Oxygen|OXYGEN]] @ 100% via BVM.
+:
 ====Age GREATER than 13 years:====
-* Assist ventilations with BVM, 100% [[Medical Gases|OXYGEN]] or Apply CPAP device as indicated.
+* Assist ventilations with BVM, 100% [[Oxygen|OXYGEN]] or Apply CPAP device as indicated.
-* [[Bronchodilators|ALBUTEROL (PROVENTIL)]] 2.5 mg via updraft or CPAP device. After second updraft of [[Bronchodilators|ALBUTEROL]], consider [[Bronchodilators|IPRATROPIUM BROMIDE (ATROVENT)]] .5 mg via updraft. [[Bronchodilators|ATROVENT]] is not for use in CHF or Cardiac Asthma. Repeat as necessary while monitoring heart rate.
+* [[Albuterol|ALBUTEROL (PROVENTIL)]] 2.5 mg via updraft or CPAP device. After second updraft of [[Albuterol|ALBUTEROL]], consider [[Atrovent|IPRATROPIUM BROMIDE (ATROVENT)]] .5 mg via updraft. [[Atrovent|ATROVENT]] is not for use in CHF or Cardiac Asthma. Repeat as necessary while monitoring heart rate.
-* If the Pt has had multiple updrafts or had previously used their own Albuterol inhaler or nebulized treatment and have not had relief. Consider [[Bronchodilators|XOPENEX (LEVALBUTEROL)]] 1.25mg nebulized via updraft.
+* If the Pt has had multiple updrafts or had previously used their own Albuterol inhaler or nebulized treatment and have not had relief. Consider [[Xopenex|XOPENEX (LEVALBUTEROL)]] 1.25mg nebulized via updraft.
-* Administer [[Corticosteroids|METHYLPREDNISOLONE (SOLU-MEDROL)]] 125 mg IVP once the breathing treatment has been initiated.
+* Administer [[Solu-Medrol|METHYLPREDNISOLONE (SOLU-MEDROL)]] 125 mg IVP once the breathing treatment has been initiated.
-* If no or inadequate response to the above, or patient is extremely anxious, consider [[Anesthetics|KETAMINE (KETALAR)]] 0.5 mg/kg IVP OR 2 mg/kg IM x 1 dose
+* If no or inadequate response to the above, or patient is extremely anxious, consider [[Ketamine|KETAMINE (KETALAR)]] 0.5 mg/kg IVP OR 2 mg/kg IM x 1 dose
 * For deteriorating patients (if no renal disease or CHF is not suspected)
-** Administer [[Electrolytes|MAGNESIUM SULFATE]] 2 gm IV in 100 ml NaCl via buretrol or secondary IV solution (piggyback), over 10-15 minutes.
+** Administer [[Magnesium Sulfate|MAGNESIUM SULFATE]] 2 gm IV in 100 ml NaCl via buretrol or secondary IV solution (piggyback), over 10-15 minutes.
 :'''If condition unimproved or patient exhibits acute hypoxia EPINEPHRINE may be administered: 1:1000 1mg/ml 0.3 - 0.5 mg IM.'''
 ====Age LESS than 13 years: SLOW ONSET====
-* [[Bronchodilators|ALBUTEROL (PROVENTIL)]] refer to Handtevy System.
+* [[Albuterol|ALBUTEROL (PROVENTIL)]] refer to Handtevy System.
 ** May administer second dosage if dyspnea unimproved.
-* If patient exhibits acute dyspnea, as evidenced by AMS, administer [[Adrenergics|EPINEPHRINE 1:1000]] 1mg/ml refer to Handtevy System
+* If patient exhibits acute dyspnea, as evidenced by AMS, administer [[Epinephrine|EPINEPHRINE 1:1000]] 1mg/ml refer to Handtevy System
-* If the patient is not responding to the above interventions, administer [[Corticosteroids|METHYLPREDNISOLONE (SOLU-MEDROL)]], refer to Handtevy System.
+* If the patient is not responding to the above interventions, administer [[Solu-Medrol|METHYLPREDNISOLONE (SOLU-MEDROL)]], refer to Handtevy System.
-* * If no or inadequate response to the above, or patient is extremely anxious, consider [[Anesthetics|KETAMINE (KETALAR)]] 0.5 mg/kg IVP OR 2 mg/kg IM x 1 dose
+* * If no or inadequate response to the above, or patient is extremely anxious, consider [[Ketamine|KETAMINE (KETALAR)]] 0.5 mg/kg IVP OR 2 mg/kg IM x 1 dose
 ====Age LESS than 13 years: RAPID ONSET====
-* In patients with rapid onset respiratory compromise due to asthma or bronchospasm, [[Bronchodilators|ALBUTEROL (PROVENTIL)]] refer to Handtevy System simultaneous with IM [[Adrenergics|EPINEPHRINE]] 1:1000 (1mg/ml) every 10-15 minutes, refer to Handtevy System.
+* In patients with rapid onset respiratory compromise due to asthma or bronchospasm, [[Albuterol|ALBUTEROL (PROVENTIL)]] refer to Handtevy System simultaneous with IM [[Epinephrine|EPINEPHRINE]] 1:1000 (1mg/ml) every 10-15 minutes, refer to Handtevy System.
-*If the Pt has had multiple updrafts or had previously used their own Albuterol inhaler or nebulized treatment and have not had relief. Consider [[Bronchodilators|XOPENEX (LEVALBUTEROL)]] nebulized via updraft refer to Handtevy System.
+*If the Pt has had multiple updrafts or had previously used their own Albuterol inhaler or nebulized treatment and have not had relief. Consider [[Xopenex|XOPENEX (LEVALBUTEROL)]] nebulized via updraft refer to Handtevy System.
 *Monitor heart rate. Continue therapy with heart rates <180-200 ages up to 6 years, <150-180 ages 6-18 years. Updrafts may need to be continuous.
-*If the patient is not responding to the above interventions, administer [[Corticosteroids|METHYLPREDNISOLONE (SOLU-MEDROL)]], refer to Handtevy System.
+*If the patient is not responding to the above interventions, administer [[Solu-Medrol|METHYLPREDNISOLONE (SOLU-MEDROL)]], refer to Handtevy System.
-*'''In the event of impending respiratory arrest and imminent death, [[Adrenergics|EPINEPHRINE]] may be administered IV or IM. (Dose for IV same as in cardiac arrest patient)'''
+*'''In the event of impending respiratory arrest and imminent death, [[Epinephrine|EPINEPHRINE]] may be administered IV or IM. (Dose for IV same as in cardiac arrest patient)'''
 [[Category:Respiratory|0301]]

← Older revision	Revision as of 13:49, 10 February 2018
(No difference)